JPRN-UMIN000001130已完成未知
Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER) - Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER)
The Research group for Arteriosclerosis treatment of The supporting Center for Clinical Research and Education : SCCRE, a nonprofit organization0 个研究点目标入组 150 人开始时间: 2008年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Contraindication of Livalo Tab (pitavastatin calcium) - Patients with a history of hypersensitivity to any of the conponents of the product - Patients with severe hepatic disorder or biliary atresia - Patients receiving cyclosporine - Pregnant women, women suspected of being pregnant, or lactating women 2) Contraindication of Bezator SR tab (bezafibrate) - Patients with renal dialysis - Patients with significant renal disease like renal failure - Patients with serum creatinine >/= 2.0 mg/dL - Patients with history of hypersensitivity to any of the ingredients of the product - Pregnant women, women suspected of being pregnant, or lactating women 3) Patients with hepatic disorders (ALT or AST >/= 100IU/L) 4) Patients with HbA1c >/= 9.0% 5) Patients with obvious steonosis in carotid artery 6) Patients who are being treated with insulin 7) Patients whom the principle investigators or other investigators consider unsuitable
研究者
相似试验
招募中
不适用
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on glucose metabolism compared to AtoRvastatin in atheroscLerotic cardiovascular disease patients with metabolic syndrome: The EZ-PEARL Randomized TrialDiseases of the circulatory systemKCT0008172Yonsei University Health System, Severance Hospital250
未知
不适用
Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathYType 2 diabetic nephropathy with HypercholesterolemiaJPRN-UMIN000001324Kyushu University Graduate School of Medical Science Department of Medicine and Bioregulatory Science100
已完成
2 期
Effectiveness of Ezetimibe or Pitavastatin calcium calcium in NASH/NAFLD patients with high cholesterol levels: a randomized controlled studyThe NASH/NAFLD patients with high cholesterol levelJPRN-UMIN000003055Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University80
招募中
Unknown
Efficacy of pitavastatin alone and in combination with ezetimibe on lipid profile in type II diabetes patients on biguanide therapy.Hyper(dys)lipidemiaDiabetes type IIJPRN-UMIN000047286BUHSC(K)75
已完成
3 期
A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemiaComplex-dyslipidemiaNCT03618797Hanlim Pharm. Co., Ltd.347